CN106279109A - A kind of preparation method of azelnidipine - Google Patents

A kind of preparation method of azelnidipine Download PDF

Info

Publication number
CN106279109A
CN106279109A CN201610683342.7A CN201610683342A CN106279109A CN 106279109 A CN106279109 A CN 106279109A CN 201610683342 A CN201610683342 A CN 201610683342A CN 106279109 A CN106279109 A CN 106279109A
Authority
CN
China
Prior art keywords
compound
azelnidipine
reaction
prepare
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610683342.7A
Other languages
Chinese (zh)
Inventor
刘超
苗华明
葛执信
肖阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Disha Pharmaceutical Group Co Ltd
Weihai Disu Pharmaceutical Co Ltd
Original Assignee
Disha Pharmaceutical Group Co Ltd
Weihai Disu Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Disha Pharmaceutical Group Co Ltd, Weihai Disu Pharmaceutical Co Ltd filed Critical Disha Pharmaceutical Group Co Ltd
Priority to CN201610683342.7A priority Critical patent/CN106279109A/en
Publication of CN106279109A publication Critical patent/CN106279109A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

The present invention relates to the preparation method of a kind of azelnidipine, belong to field of medicaments, open new way for synthesizing dihydro pyridines calcium antagonist.The method is with nitrile acetic acid as raw material, 2 amino 3 carboxyls 1 are synthesized successively through Pinner reaction, Hantzsch, 4 dihydro 6 methyl 4 (3 nitrobenzophenone) 5 isopropyl formates, prepare azelnidipine crude product with 1 benzhydryl 3 hydroxy azetidine hydrochlorate through DCC dehydration esterification again, turn crystalline substance further and obtain the azelnidipine of alpha-crystal form.

Description

A kind of preparation method of azelnidipine
Technical field
The present invention relates to the preparation method of a kind of azelnidipine, belong to pharmaceutical technology field.
Background technology
Azelnidipine (Azelnidipine) is Sankyo Co., Ltd of Japan and Ube Industries, Ltd's joint development A kind of dihydropyridine calcium channel blocker, has good antihypertensive function, lists in Japan first in May, 2003:
List of references about azelnidipine preparation method is a lot of the most both at home and abroad, such as European patent EP 0266922;China is specially Profit ZL87107150;Chem. Pharm. Bull.43(5), 1995, P788-796;The clear 63-253082 of TOHKEMY;JP Laid-Open 11-116570;Drug of Future Vol.15, NO.7,1990, P671-673 etc..The preparation method that these routes are provided It is all that (m-nitrobenzaldehyde a, isopropyl acetoacetate b) and compound c are in strong basicity by compound 3 or two synthesis material Under the conditions of, with isopropanol as solvent, the prepared azelnidipine of high temperature reflux reaction (as shown in reaction equation 1 or 2):
Reaction equation 1:
Reaction equation 2:
Wherein, the synthesis of compound c with epoxychloropropane and .alpha.-aminodiphenylmethane. as initiation material, through N-alkylation cyclization, esterification, Pinner reaction obtains:
Chinese patent 200510104895.4(page 7) preparation method that uses document to provide according to reaction equation 1 prepares Ah folding ground At ordinary times, finding complex operation, and yield, quality are the most undesirable, actual recovery only has about 15%, the yield provided with document 85.6% differs greatly.
Open closely related group etc. to disclose in " synthesis of antihypertensive nitrendipine " (" medical industry ", 1984,15:41) The reaction under conditions of dehydrated alcohol, backflow of 3-nitrobenzaldehyde, ethyl acetoacetate and β-amino crotonate generates nitre benzene Horizon:
Although the method has certain advantage when preparing nifedipine, but after β-amino crotonate is replaced with compound c But azelnidipine is hardly resulted in by the method.Its reason is probably: compound c chemical group is relatively big, chemical property compared to β-amino crotonate changes the most greatly, and ring butylamine and diphenyl make spatial obstacle increase, and has slackened the work of Hantzsch reaction Property.
Summary of the invention
It is an object of the invention to provide the preparation method of a kind of azelnidipine.
The technical scheme is that the preparation method of a kind of azelnidipine, it is characterised in that
The first step, can selectively be carried out
(1) compound 1 is under dehydrated alcohol, dry hydrogen chloride gas effect, reaction preparation amidine acetic acid 2, or
(2) .alpha.-aminodiphenylmethane. and epichlorohydrin reaction prepare compound 5;
Second step, compound 2 and compound 3 prepare compound 4 under alkali effect;
3rd step, compound 4 and compound 5 prepare azelnidipine by dehydration esterification.
According to the present invention, when preparing described compound 5, first .alpha.-aminodiphenylmethane. is stirred with epoxychloropropane at room temperature shading Mix to substrate reactions complete, then reaction system is transferred in autoclave heating, it is preferred that in autoclave, Stress control is at 1- 2MPa, reaction temperature controls at 150-160 DEG C.
According to the invention it is preferred to, alkali used by second step course of reaction is Feldalat NM.
According to the present invention, when the 3rd step compound 4 prepares azelnidipine with compound 5, esterification is anti-to use dehydrant to promote The carrying out answered, dehydrant is preferredN, N '-dicyclohexylcarbodiimide (DCC).
Traditional route is when being prepared compound c by compound 6, owing to there is ester exchange side reaction under the conditions of HCl/EtOH, Can produce following by-product:
When using route disclosed by the invention to prepare amidine acetic acid 2, then can avoid above-mentioned two by-product completely to finished product Impact:
The invention has the beneficial effects as follows, compound 4 is the key intermediate of synthesis azelnidipine, first by compound 2 and compound 3 This dihydropyridine parent nucleus is synthesized, when significantly reducing final step ring-closure reaction in linear type synthesis technique through Hantzsch The impurity existed is many, and purification difficulty is big, the low equal pressure of yield, and this strategy is more beneficial for improving product quality, meets medicinal mark Quasi need.
Detailed description of the invention:
Content for a better understanding of the present invention, is described further below in conjunction with specific embodiment, but the present invention is not only limited to This.
Embodiment 1
First step Pinner is reacted
Dichloromethane 750g, dehydrated alcohol 65.65g(1.43mol it is sequentially added in reaction bulb) and nitrile acetic acid 120g (1.42mol) (compound 1), mix and blend, is cooled to-10 DEG C ~ 0 DEG C.It is passed through dry hydrogen chloride gas to saturated, insulation Reaction 8 ~ 12h is to terminal.Reduced pressure at room temperature recycling design, adds dichloromethane 600g in residue, and mix and blend being cooled to- 5 DEG C ~ 0 DEG C, being passed through dry ammonia to saturated, insulation reaction 3 ~ 5h is to terminal.Reduced pressure at room temperature recycling design is to doing to obtain amidine second Acid (compound 2) 137.4g.This step yield is 94.8%, and HPLC purity is 99.6%.
Second step Hantzsch reacts
Isopropanol 520g, amidine acetic acid 106g(1.04mol it is sequentially added in reaction bulb) (compound 2) and 288.6g (1.06mol) compound 3, mix to dissolve completely, are subsequently added Feldalat NM 57.3g(1.06mol), it is heated to backflow anti- Answer 6 ~ 8h.TLC monitors reaction end, is down to 0 ~ 5 DEG C, insulation crystallize 2 hours.Filter cake is collected by filtration, 50 ~ 60 DEG C of forced air dryings, Obtain 2-amino-3-carboxyl-1,4-dihydro-6-methyl-4-(3-nitrobenzophenone)-5-isopropyl formate (compound 4) 315.3g.This Step yield is 83.9%, and HPLC purity is 98.9%.
3rd step addition, cyclization
In reaction bulb, be sequentially added into methanol 400g .alpha.-aminodiphenylmethane. 270g(1.47mol), epoxychloropropane 142.5g (1.54mol), room temperature shading stirring reaction 48h, HPLC detection .alpha.-aminodiphenylmethane. surplus no more than 0.2% is considered as reaction end, will Feed liquid is transferred in autoclave, and under nitrogen protection, (pressure limit is: 1-2MPa) react 4 ~ 6h in 150 ~ 160 DEG C.Cooling To room temperature.Concentrating under reduced pressure falls the solvent of more 1/2 volume, and after being cooled to 0 ~ 10 DEG C, growing the grain 1h, is collected by filtration filter cake.By filter cake second Acetoacetic ester 125g pulls an oar, and sucking filtration obtains off-white color solid 251.4g(compound 5, it may be assumed that 1-benzhydryl-3-hydroxy azetidine Hydrochlorate).This step yield is 62.0%, and HPLC purity is 99.2%.
4th step esterification
Dichloromethane 2.17kg, compound (4) 271g(0.75mol it is sequentially added in reaction bulb) and compound (5) 215g (0.90mol), stirring mixing, it is cooled to 0 ~ 10 DEG C.It is slowly added toN, N '-dicyclohexylcarbodiimide, finishes, and continues insulation and stirs Mix 0.5 hour.Subsequently, being warming up to 50 ~ 60 DEG C, insulation reaction 8 ~ 10 hours is to reaction end.It is cooled to-5 ~ 5 DEG C, filters, subtract Pressure recycling design.In residue, add methanol 1.80L, recrystallization, obtain product 398.5g(azelnidipine crude product).This step yield Being 91.2%, HPLC purity is 99.6%.
5th step crude product refining
In reaction bulb, it is sequentially added into azelnidipine crude product 400g, ethyl acetate/normal hexane (2:1, V/V) 4L, stirring mixing, delays Slowly material dissolution it is warming up to.Adding activated carbon 20g, insulation decolouring 0.5h, filtered while hot, filtrate is cooled to 0 ~ 5 DEG C of crystallize.Cross Filter, collects product, and in air dry oven, 50 ~ 60 DEG C are dried.Obtain azelnidipine fine work 381.2g.This step yield is 95.3%, HPLC purity 99.7%.
This route total recovery is: 42.9%.

Claims (1)

1. the new preparation process of an azelnidipine, it is characterised in that:
The first step, can selectively be carried out
(1) compound 1 is under dehydrated alcohol, dry hydrogen chloride gas effect, reaction preparation amidine acetic acid 2, or
(2) .alpha.-aminodiphenylmethane. and epichlorohydrin reaction prepare compound 5;
Second step, amidine acetic acid 2 and compound 3 prepare compound 4 under alkali effect;
3rd step, compound 4 and compound 5 prepare azelnidipine by dehydration esterification;
Wherein, when preparing compound 5, first by complete to substrate reactions with epoxychloropropane at room temperature shading stirring for .alpha.-aminodiphenylmethane. Finish, then reaction system is transferred in autoclave heating, it is preferred that in autoclave, Stress control is in 1-2MPa, reaction temperature control System is at 150-160 DEG C.
CN201610683342.7A 2016-08-18 2016-08-18 A kind of preparation method of azelnidipine Pending CN106279109A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610683342.7A CN106279109A (en) 2016-08-18 2016-08-18 A kind of preparation method of azelnidipine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610683342.7A CN106279109A (en) 2016-08-18 2016-08-18 A kind of preparation method of azelnidipine

Publications (1)

Publication Number Publication Date
CN106279109A true CN106279109A (en) 2017-01-04

Family

ID=57678770

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610683342.7A Pending CN106279109A (en) 2016-08-18 2016-08-18 A kind of preparation method of azelnidipine

Country Status (1)

Country Link
CN (1) CN106279109A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108707106A (en) * 2018-06-15 2018-10-26 青岛科技大学 A kind of Azelnidipine impurity and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102453023A (en) * 2010-10-21 2012-05-16 大丰市天生药业有限公司 Process for producing azelnidipine
CN103509003A (en) * 2012-06-27 2014-01-15 威海威太医药技术开发有限公司 Preparation method of azelnidipine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102453023A (en) * 2010-10-21 2012-05-16 大丰市天生药业有限公司 Process for producing azelnidipine
CN103509003A (en) * 2012-06-27 2014-01-15 威海威太医药技术开发有限公司 Preparation method of azelnidipine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘剑峰等: "阿折地平的合成工艺改进", 《中国药物化学杂志》 *
陈国斌等: "阿折地平的合成及其结晶的研究", 《化学工业与工程》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108707106A (en) * 2018-06-15 2018-10-26 青岛科技大学 A kind of Azelnidipine impurity and preparation method thereof

Similar Documents

Publication Publication Date Title
CN108718527B (en) Process for preparing compounds
CN107365275B (en) High purity celecoxib
CN101367759B (en) Synthesis of high-purity amlodipine besylate
EP2207777A2 (en) Polymorphs of dasatinib and process for preparation thereof
EP3257855B1 (en) Method for preparing ibrutinib
CN114014874B (en) Preparation method of Mabalo Sha Wei intermediate
CN106543060A (en) It is a kind of it is difficult to understand this for Buddhist nun's mesylate preparation method
WO2011007368A2 (en) An improved process for preparation of olmesartan
CN106279109A (en) A kind of preparation method of azelnidipine
CN101337966A (en) Method for preparing high-purity irinotecan
CN106496201A (en) A kind of preparation method of avanaphil crude drug
CN109734656B (en) Preparation method of nitrendipine
CN103130700B (en) Preparation method of azelnidipine intermediate
IL297470A (en) Synthesis of a monoacylglycerol lipase inhibitor
CN111138492B (en) Preparation method of ALK inhibitor brigatinib
CN108503586B (en) Process for the preparation of tolvaptan intermediates
CN103373956A (en) Method for preparing clevidipine butyrate
US11932614B2 (en) Method for preparing diazoxide
CN102516159B (en) Method for producing S-(-)-amlodipine besylate
CN101955459A (en) Method for preparing blonanserin
CN105884746A (en) Synthesizing method of flumatinib
CN110698529A (en) Preparation method of eplerenone intermediate △ 9,11 alkenyl ester
CN114149360B (en) Preparation method of high-purity nitrendipine bulk drug
CN109651234A (en) A kind of synthetic method of Doneppezil Hydrochloride
CN111019016B (en) Synthesis method of sugammadex impurity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170104

RJ01 Rejection of invention patent application after publication